BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han M, Yeşil ÖD, Başaran GŞ, Sezer G, Telci D, Küçükgüzel Ş. Design, synthesis and anticancer activity studies of novel 4-butylaminophenyl hydrazide-hydrazones as apoptotic inducers. Tetrahedron 2022. [DOI: 10.1016/j.tet.2022.132797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Coşkun GP, Sahin Z, Erdoğan Ö, Çevik Ö, Biltekin SN, Yurttas L, Berk B, Ülgen M, Demirayak Ş. Discovery of novel potent human chondrosarcoma (SW1353) inhibitors: 4-(2/3/4-pyridyl)thiazole 2-acetamide derivatives. Journal of Molecular Structure 2023;1273:134260. [DOI: 10.1016/j.molstruc.2022.134260] [Reference Citation Analysis]
2 Bhattacharya S, Sharma S, Prajapati BG. Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.990841] [Reference Citation Analysis]